CANCER 2026 Max Nobis
Garvan Institute of Medical Research The Kinghorn Cancer Centre, NSW, Australia
Presentations this author is a contributor to:
Mechanisms of oncogenic JNK signalling in metastatic triple-negative breast cancer (#134)
5:40 PM
Misaki S Clearwater
Welcome Reception & Poster Session 1
Temporally resolved proteomics identifies nidogen-2 as a co-target in pancreatic cancer that modulates fibrosis and therapy response (#235)
5:35 PM
Brooke Pereira
Poster Session 2
Pancreatic cancer secretome reveals PCSK9 as a co-target to sensitise tumours to chemotherapy and reduce metastasis (#244)
5:35 PM
Shona Ritchie
Poster Session 2